PsyPal Project @psypaleu.bsky.social An EU-funded project investigating psilocybin therapy for individuals with palliative care needs.
EU Project no. 101137378
https://palliativeprojects.eu/psypal/ 
Max Bayer @maxbayer.bsky.social Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or maxbayer.10 on Signal. he/him
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social The Center for Psychedelic and Consciousness Research studies how psychedelics affect behavior, mood, cognition, brain function, & biological markers of health.
https://linktr.ee/jhpsychedelics
dan karlin @dankarlin.com cmo @ mindmed
assistant professor of psychiatry @ tufts
ultimately, just dan
Srinivas Rao @srinigrao.bsky.social Co-CEO and Co-Founder of atai Life Sciences (www.atai.life). Opinions expressed are my own.
Portland Institute for Psychedelic Science (PIPS) @pips-crc.bsky.social PIPS advances psychedelic research and therapies through evidence-based practices. We provide clinician training, integration services for independent explorers, & Psilocybin Wrap-Around Psychotherapy Program supporting legal psilocybin sessions in Oregon.
Rachel Nuwer @rachelnuwer.bsky.social Freelance science journalist contributing to NYT, SciAm, Nature etc. Author of "Poached: Inside the Dark World of Wildlife Trafficking" (2018) and "I Feel Love: MDMA and the Quest for Connection in a Fractured World" (2023). 
Joe Moore @jomo137.bsky.social CEO @ Psychedelics Today
psychedelicstoday.com
https://linktr.ee/jomo137
Michael Alpert 艾瑞祥 @mdmalpert.bsky.social M.D. Psychiatrist, MDMA and psychedelic researcher @Lykos. Psychiatry Faculty @HMS (Harvard Medical School), @BIDMC. Musician, rock climber, kombucha brewer, cat lover. 會說中文
Qualia Research Institute @qualiari.bsky.social QRI is a non-profit institute developing mathematical models of consciousness through innovative exploration of subjective experience.
Check out our research and unique approach at QRI.org.
Jason Luoma, Ph.D. @jasonluoma.bsky.social Psychedelics, MDMA, and shame researcher, treatment developer, author, psychologist, and therapy trainer, at the Portland Institute for Psychedelic Science.
Joelle Adams | The Psychedelic Professor @joelleadams.bsky.social Researcher, lecturer, coach, PhD candidate in Applied Transpersonal Psychology with a focus on psychedelics and exceptional experiences. www.joelleadams.com
Sam Chapman @seriouslysamuel.bsky.social U.S. Psychedelic Policy & Politics
Founder @ Toolbox Strategies
Fmr Campaign Manager @ Oregon Measure 109
Joanna Kempner @joannakempner.bsky.social Sociologist and Pet Snoozler. Kid Herder and Hobby Hoarder. Award-winning author focused on gender, health, pain, and stigma. New book: Psychedelic Outlaws about pain patients figuring things out on their own. https://bit.ly/psychedelicoutlaws
Eduardo Schenberg, PhD @eeschenberg.bsky.social Neuroscience and Science Diplomacy
Psychedelic sciences critical thinking
Associate Researcher at ULisbon 🇵🇹 Affiliated Researcher at Petrie-Flom Center, Harvard U. 🇺🇸
Honorary Researcher at LAB lab, UCL 🇬🇧
www.eduardoschenberg.com
Financial Times @financialtimes.com The best of FT journalism, including breaking news and analysis.
https://www.ft.com
The users this account follows are verified FT staff or contributors.
The Washington Post @washingtonpost.com Democracy Skies in Blueness
The Times and Sunday Times @thetimes.com 🗞️ The best of our journalism
👉 https://www.thetimes.com/
Business Insider @businessinsider.com What you want to know about business.
Follow us on Facebook, Instagram, and YouTube.
Visit our homepage for the day's top stories.
Love Business Insider? Add us as a preferred source on Google.
businessinsider.com
Endpoints News @endpts.com We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com. 
The Wall Street Journal @wsj.com Since 1889 🗞️
Sign up for our newsletters and alerts: http://wsj.com/newsletters
Got a tip? http://wsj.com/tips
Follow our staff: https://go.bsky.app/2ppWqxF
The New York Times @nytimes.com We seek the truth and help people understand the world. Not a subscriber? Your first month is now free in our app. https://nytimes.onelink.me/Xpht/zbx4nci9
STAT @statnews.com Reporting from the frontiers of health & medicine.
Explore all of our newsletters here: https://www.statnews.com/signup/
Reuters @reuters.com 
@psychedelicscience.bsky.social @psychedelicscience.bsky.social 
@beckleypsytech.bsky.social @beckleypsytech.bsky.social 
MindMed @mindmed.co 
Multidisciplinary Association for Psychedelic Studies🧬 @mapsorg.bsky.social Est.1986
Promoting medical, legal & cultural progress through psychedelic & marijuana research.
Psychedelic Cases Bot @psychedelic.bots.law Real-time updates on Psychedelic cases. Curated by Psychedelic Alpha and the Psychedelic Bar Association. Hosted by @free.law.
Also at @psychedelic_cases@mastodon.social and @psy_cases on X.
Details: https://bots.law/little-cases/psychedelic-cases-bots/
josh hardman @josh-hardman.bsky.social full of microplastics and writing about psychedelics at psychedelicalpha.com ( @psychedelicalpha.bsky.social )
Psychedelic Alpha @psychedelicalpha.bsky.social 
Bluesky @bsky.app official Bluesky account (check username👆)
Bugs, feature requests, feedback: support@bsky.app